Please use this identifier to cite or link to this item:
Title: Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
Authors: Van Heirstraeten, Liesbet
Coenen, Samuel
Lammens, Christine
HENS, Niel 
Goossens, Herman
Malhotra-Kumar, Surbhi
Issue Date: 2012
Source: EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518
Abstract: In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.
Notes: Malhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium.
Keywords: Immunology; Infectious Diseases
Document URI:
ISSN: 1080-6040
e-ISSN: 1080-6059
DOI: 10.3201/eid1809.120049
ISI #: 000307989700024
Category: A1
Type: Journal Contribution
Validations: ecoom 2013
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdfpublished version312.48 kBAdobe PDFView/Open
Show full item record

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.